Treating port wine stain birthmarks by using dynamic optical coherence tomography–guided settings - 14/12/22
Doi : 10.1016/j.jaad.2019.08.028
Mitalee P. Christman, MD a, b, ⁎ 
, Hao Feng, MD, MHS a, b, Jon Holmes, MA, FInstP c, Roy G. Geronemus, MD a, b
, Hao Feng, MD, MHS a, b, Jon Holmes, MA, FInstP c, Roy G. Geronemus, MD a, b a Laser and Skin Surgery Center of New York, New York, New York
b The Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York
c Michelson Diagnostics Ltd, Maidstone, United Kingdom
∗Reprint requests: Mitalee P. Christman, MD, Laser and Skin Surgery Center of New York, 317 East 34th St, 11th Floor, New York, NY 10016.Laser and Skin Surgery Center of New York317 East 34th St, 11th FloorNew YorkNY10016
Key words : birthmark, optical coherence tomography, port wine stain, pulsed dye laser
Plan
| Funding sources: None. |
|
| Conflicts of interest: Mr Holmes is an employee and shareholder of Michelson Diagnostics Ltd, which manufactures the optical coherence tomography equipment used in this study. Dr Geronemus has served on the Medical Advisory Board for Allergan, Candela, Cearna, Cynosure, Cytrellis, Lutronic, and Soliton; has served as an investigator for Allergan, ArchiMedus, Avava, Candela, Cynosure, Cytrellis, Endo Pharmaceuticals, Galderma, Kerastem, Lutronic, Merz, New York Stem Cell Foundation, Pulse Biosystems, Quanta, Revance, Sciton, Sienna Labs, and Michelson Diagnostics Ltd; and is a stockholder of Cytrellis. Dr Christman and Dr Feng have no conflicts of interest to disclose. |
© 2019
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 88 - N° 1
P. e11-e13 - janvier 2023 Retour au numéro
Article précédent
- A novel technique to safely maximize botulinum toxin extraction from 50-unit vials
- Isadore S. Tarantino, Brett C. Neill, Melanie N. Wolf, Anand Rajpara, Daniel J. Aires
- Reply to: “Comment on ‘Risk of skin cancer in HIV-infected patients: A Danish nationwide cohort study’”
- Silje H. Omland, Lars H. Omland
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?